Male Contraceptive Pill Could Immobilise Sperm In Just 30 Minutes: What Scientists Have Found

Scientists Develop Experimental Male Contraceptive Pill That Could Temporarily Immobilise Sperm

For decades, contraception has largely placed the responsibility on women, with men having relatively few options beyond condoms and vasectomy. Scientists are now exploring a potential alternative: an experimental male birth control pill designed to temporarily stop sperm from moving and prevent fertilisation.

Researchers at Weill Cornell Medicine in the United States are developing a non-hormonal contraceptive that targets sperm movement rather than permanently affecting male fertility. Early research indicates that the drug could begin working within around 30 minutes of consumption, with its effects potentially continuing for six to eight hours.

The proposed approach could offer men an on-demand contraceptive option without surgery or hormonal intervention. However, the findings remain preliminary, and the reported effectiveness and duration have not been confirmed through human clinical trials.

How Does The New Male Contraceptive Work?

The research led by Dr Jochen Buck and Dr Lonny Levin focuses on an enzyme known as soluble adenylyl cyclase (sAC).

This enzyme is essential for sperm motility, the ability of sperm to swim and move towards an egg. By temporarily blocking sAC, scientists aim to prevent sperm from swimming efficiently enough to achieve fertilisation.

The experimental drug is designed to inhibit the enzyme’s activity for a limited period. When its effects wear off, normal enzyme activity is expected to resume, potentially restoring sperm movement and fertility.

This mechanism could make the pill different from conventional male contraceptive approaches because it aims to provide temporary rather than permanent contraception.

What Are The Possible Risks And Side Effects?

Although initial animal experiments have reportedly shown no obvious adverse effects, the drug’s safety in humans has yet to be established.

Scientists must determine whether blocking sAC has unintended effects elsewhere in the body. They will also need to examine the consequences of repeated use, identify possible side effects and establish a safe and effective dosage.

The results of animal studies cannot guarantee that the same safety profile will apply to humans.

When Will The Pill Become Available?

The experimental male contraceptive has not yet completed the testing required for public use. Researchers are working towards human trials, which will be essential to establish its safety and contraceptive effectiveness.

Clinical studies will need to confirm whether the drug can reliably prevent pregnancy, how quickly it takes effect, how long protection lasts and whether male fertility returns completely after the drug wears off.

If successful, the research could open the door to a new generation of reversible, non-hormonal contraceptives for men. However, the pill is still experimental, and widespread availability will depend on further testing and regulatory approval.